Citation only
via Europe PMC
Lepr Haploinsufficiency Accelerates Alzheimer-like Neurodegeneration via CDK5 Hyperactivation.
Paul S, Bhardwaj J, Sharma S, Swalih M, Koul D, Bk B.
The Journal of biological chemistry · 2026
Abstract
Leptin receptor (LEPR) signaling plays a critical role in neuronal survival and synaptic function and is increasingly implicated in Alzheimer's disease (AD) pathogenesis. Beyond its metabolic actions, leptin regulates β-amyloid homeostasis, tau phosphorylation, and synaptic plasticity. While the neurological consequences of homozygous leptin receptor (Lepr) mutations are well characterized, the impact of heterozygous Lepr deficiency on brain aging and neurodegeneration remains unclear. To address this, we analyzed heterozygous leptin receptor mutant (db/+) mice at 6 and 12 months of age using metabolic, behavioral, biochemical, neuropathological, and transcriptomic approaches. Young db/+ mice were comparable to controls, whereas aged db/+ mice developed obesity, impaired glucose tolerance, and insulin resistance, accompanied by deficits in spatial learning and motor coordination. Aged db/+ brains exhibited elevated amyloid-β42 levels, increased CDK5 kinase activity, and hyperphosphorylation of tau at Ser396 and Thr231. Although total LEPR protein levels were unchanged, phosphorylation of STAT3 at Tyr705 was significantly reduced, indicating impaired downstream LEPR signaling. Transcriptomic profiling revealed downregulation of genes involved in synaptic signaling and plasticity, including Gabrb2, Brsk1, Camk2a, Syn1, and Syngap1, along with alterations in neurotransmitter and oxidative phosphorylation pathways. Collectively, these findings demonstrate that leptin receptor haploinsufficiency promotes age-dependent metabolic dysfunction, synaptic failure, and CDK5-mediated tauopathy, leading to Alzheimer-like neurodegeneration and identifying LEPR as a potential genetic risk factor and therapeutic target.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.jbc.2026.113749
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
S, P., J, B., S, S., M, S., D, K., & B., B. (2026). Lepr Haploinsufficiency Accelerates Alzheimer-like Neurodegeneration via CDK5 Hyperactivation. <em>The Journal of biological chemistry</em>. https://doi.org/10.1016/j.jbc.2026.113749
Vancouver
S P, J B, S S, M S, D K, B. B. Lepr Haploinsufficiency Accelerates Alzheimer-like Neurodegeneration via CDK5 Hyperactivation. The Journal of biological chemistry. 2026. doi:10.1016/j.jbc.2026.113749.
BibTeX
@article{paul2026LeprHa,
title = {Lepr Haploinsufficiency Accelerates Alzheimer-like Neurodegeneration via CDK5 Hyperactivation.},
author = {Paul S and Bhardwaj J and Sharma S and Swalih M and Koul D and Bk B.},
journal = {The Journal of biological chemistry},
year = {2026},
doi = {10.1016/j.jbc.2026.113749},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Clinical Investigation 2011
Open access · OA
IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease
Journal of Cerebral Blood Flow & Metabolism 2022
Preprint · OA
Aging related impairment of brain microvascular bioenergetics involves oxidative phosphorylation and glycolytic pathways
Molecular biomedicine 2026
Open access · OA
Targeted neuronal reprogramming rescues memory and neural synchrony in Alzheimer's disease.
Nature Aging 2024
Open access · CC-BY
Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction
Basic & clinical pharmacology & toxicology 2026
Open access · OA
The Crosstalk Between Diabetes and Alzheimer's Disease: A Molecular Perspective.
Molecular neurobiology 2026
Citation only